ng-nitroarginine methyl ester has been researched along with Muscle Weakness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barisic, I; Drmic, D; Katancic, J; Kolenc, D; Medvidovic-Grubisic, M; Murselovic, T; Plestina-Borjan, I; Seiwerth, S; Sikiric, P; Sindic, A; Stambolija, V; Strbe, S | 1 |
| Chen, HI; Hsu, BG; Hsu, YH | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Muscle Weakness
| Article | Year |
|---|---|
Hypermagnesemia disturbances in rats, NO-related: pentadecapeptide BPC 157 abrogates, L-NAME and L-arginine worsen.
Topics: Amino Acid Sequence; Animals; Anti-Ulcer Agents; Arginine; Drug Therapy, Combination; Enzyme Inhibitors; HEK293 Cells; Humans; Magnesium Sulfate; Male; Muscle Weakness; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Proteins; Rats; Rats, Wistar | 2017 |
Malignant alterations following early blockade of nitric oxide synthase in hypertensive rats.
Topics: Animals; Blood Pressure; Blood Urea Nitrogen; Body Weight; Endothelin-1; Enzyme Inhibitors; Glomerular Filtration Rate; Hypertension; Isothiuronium; Kidney; Kidney Function Tests; Lysine; Muscle Weakness; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Nitroarginine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Ventricular Function, Left | 2007 |